The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2020

Filed:

Apr. 13, 2018
Applicant:

Salk Institute for Biological Studies, La Jolla, CA (US);

Inventors:

Ronald M. Evans, La Jolla, CA (US);

Michael Downes, San Diego, CA (US);

Annette Atkins, San Diego, CA (US);

Ruth T. Yu, La Jolla, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); C07K 14/50 (2006.01); A61K 31/7088 (2006.01); A61P 3/10 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61K 31/573 (2013.01); A61K 31/7088 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01); C07K 14/50 (2013.01); C07K 14/501 (2013.01); C07K 2319/70 (2013.01);
Abstract

Methods of using FGF1 analogs, such as FGF1 mutant proteins having an N-terminal deletion, point mutation(s), or combinations thereof, to reduce blood glucose levels in subjects with steroid-induced diabetes, hypercortisolemia, or diabetes due to treatment with an antipsychotic agent, are provided. Such mutant FGF1 proteins can be part of a chimeric protein that includes a β-Klotho-binding protein, an FGFR1-binding protein, a β-Klotho-binding protein and a FGFR1-binding protein, a C-terminal region from FGF19 or FGF21.


Find Patent Forward Citations

Loading…